ADIL

Quote

Short

News

Articles

Message Board

Expected earnings - Adial Pharmaceuticals Inc

August 12, 2025 05:31:09 am

Source: US Earnings Reports

Adial Pharmaceuticals Inc (ADIL) is expected to report $-0.22 for Q2 2025

Adial Pharmaceuticals Inc

NASDAQ: ADIL

ADIL Trading

3.0% G/L:

$1.90 Last:

17,248 Volume:

$1.89 Open:

mwn-ir Ad 300

ADIL Latest News

March 09, 2026 06:38:23 pm

ADIL - Historical Price Movements Surrounding Earnings

March 06, 2026 08:00:00 am

Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update

March 03, 2026 08:17:00 am

Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in Potential Royalties and Milestones upon execution of a Definitive Agreement

March 03, 2026 06:00:51 am

Expected US Company Earnings on Tuesday, March 3rd, 2026

ADIL Stock Data

Market Cap $3,344,622

Float 1,090,503

Insiders Ownership 4.47%

Institutions 7

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.adial.com

Country US

City Glen Allen

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App